{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T14:28:44Z","timestamp":1788618524546,"version":"build-2803163510"},"reference-count":42,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Migraine is a common neurological disease with a high disability burden. Despite this, many people with migraine do not take medication to prevent attacks, even when this is indicated. Many non-pharmacological approaches to migraine treatment exist, but little is known about how people with migraine use these options. Methods: The online Migraine in Aotearoa New Zealand (NZ) Survey collected responses from 530 people with migraine from August to October 2022. Questions included current and previous use of preventive medications, supplements (e.g., magnesium, riboflavin, coenzyme Q10) and complementary therapies (e.g., meditation, biofeedback, yoga, acupuncture). Results: Around half of the respondents were currently using a supplement, 58% were currently using complementary therapy and half were taking preventive medication. One in five were using all three approaches for migraine prevention. Of those not taking preventive medication, 44% were taking a supplement, and 53% were using complementary therapy. For commonly used non-pharmacological approaches, 20\u201330% of people had tried them in the past but stopped due to lack of efficacy or other reasons. A high proportion of people would like to try approaches that are not readily available or expensive in NZ (e.g., neurostimulation devices and biofeedback). Conclusions: The use of supplements and complementary therapies for migraine prevention is common, often in combination with medication. There are high levels of discontinuation due to ineffectiveness and cost prohibits use for many. Improved access to non-pharmacological therapies, particularly as an adjunct, has the potential to improve outcomes for people with migraine, but more and better migraine treatment options are also needed.<\/jats:p>","DOI":"10.3390\/jcm14124023","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T09:02:03Z","timestamp":1749200523000},"page":"4023","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Use of Non-Pharmacological Approaches for Migraine Treatment: Results from the Migraine in Aotearoa New Zealand Survey"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8472-7108","authenticated-orcid":false,"given":"Fiona","family":"Imlach","sequence":"first","affiliation":[{"name":"Department of Public Health, University of Otago Wellington, Wellington 6242, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3079-369X","authenticated-orcid":false,"given":"Susan","family":"Garrett","sequence":"additional","affiliation":[{"name":"Department of Primary Health Care and General Practice, University of Otago Wellington, Wellington 6242, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Steiner, T.J., Hus\u00f8y, A., and Stovner, L.J. (2024). GBD2021: Headache Disorders and Global Lost Health\u2014A Focus on Children, and a View Forward. J. Headache Pain., 25.","DOI":"10.1186\/s10194-024-01795-2"},{"key":"ref_2","unstructured":"Global Burden of Disease Collaborative Network (2024, June 12). Global Burden of Disease Study 2021 (GBD 2021) Results. Available online: https:\/\/vizhub.healthdata.org\/gbd-results\/."},{"key":"ref_3","first-page":"54","article-title":"The Impact of Living with Migraine Disease in Aotearoa New Zealand","volume":"137","author":"Garrett","year":"2024","journal-title":"N. Z. Med. J."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018). The International Classification of Headache Disorders, 3rd Edition. Cephalalgia, 38, 1\u2013211.","DOI":"10.1177\/0333102417738202"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/head.12878","article-title":"A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability","volume":"56","author":"Lipton","year":"2016","journal-title":"Headache"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/head.14153","article-title":"The American Headache Society Consensus Statement: Update on Integrating New Migraine Treatments into Clinical Practice","volume":"61","author":"Ailani","year":"2021","journal-title":"Headache J. Head Face Pain"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Manack Adams, A., Lanteri-Minet, M., Leroux, E., Katsarava, Z., Lipton, R.B., Sakai, F., Matharu, M., Fanning, K., Sommer, K., and Seminerio, M. (2024). Characterizing Barriers to Care in Migraine: Multicountry Results from the Chronic Migraine Epidemiology and Outcomes-International (CaMEO-I) Study. J. Headache Pain, 25.","DOI":"10.1186\/s10194-024-01834-y"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Groth, M., Katsarava, Z., and Ehrlich, M. (2022). Results of the GErman Migraine PatIent Survey on Medical Care and PrOPhylactic Treatment Experience (EPISCOPE). Sci. Rep., 12.","DOI":"10.1038\/s41598-022-08716-w"},{"key":"ref_9","first-page":"22","article-title":"Systematic Review of Migraine Prophylaxis Adherence and Persistence","volume":"20","author":"Hepp","year":"2014","journal-title":"J. Manag. Care Pharm."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/0333102416678382","article-title":"Persistence and Switching Patterns of Oral Migraine Prophylactic Medications among Patients with Chronic Migraine: A Retrospective Claims Analysis","volume":"37","author":"Hepp","year":"2017","journal-title":"Cephalalgia"},{"key":"ref_11","first-page":"65","article-title":"Use of Medications for Migraine in Aotearoa New Zealand","volume":"137","author":"Imlach","year":"2024","journal-title":"N. Z. Med. J."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Wells, R.E., Beuthin, J., and Granetzke, L. (2019). Complementary and Integrative Medicine for Episodic Migraine: An Update of Evidence from the Last 3 Years. Curr. Pain Headache Rep., 23.","DOI":"10.1007\/s11916-019-0750-8"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/WNO.0000000000000841","article-title":"Complementary and Integrative Health Treatments for Migraine","volume":"39","author":"Patel","year":"2019","journal-title":"J. Neuroophthalmol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/head.13555","article-title":"Evidence-Based Integrative Treatments for Headache","volume":"59","author":"Kuruvilla","year":"2019","journal-title":"Headache J. Head Face Pain"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Millstine, D., Chen, C.Y., and Bauer, B. (2017). Complementary and Integrative Medicine in the Management of Headache. BMJ, 357.","DOI":"10.1136\/bmj.j1805"},{"key":"ref_16","first-page":"S41","article-title":"The Use of Complementary and Alternative Medicine in Patients with Migraine","volume":"50","year":"2012","journal-title":"Arch. Neuropsychiatry"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/fct.12185","article-title":"Complementary and Alternative Medicine for the Prevention and Treatment of Migraine Headache: An Overview of Systematic Reviews","volume":"20","author":"Posadzki","year":"2015","journal-title":"Focus Altern. Complement. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s11916-023-01162-x","article-title":"Non-Pharmacological Treatment for Chronic Migraine","volume":"27","author":"Han","year":"2023","journal-title":"Curr. Pain. Headache Rep."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Moisset, X., Pereira, B., Ciampi De Andrade, D., Fontaine, D., Lant\u00e9ri-Minet, M., and Mawet, J. (2020). Neuromodulation Techniques for Acute and Preventive Migraine Treatment: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J. Headache Pain, 21.","DOI":"10.1186\/s10194-020-01204-4"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1468-2982.2009.01841.x","article-title":"Use of Complementary and Alternative Medicine in Patients Suffering from Primary Headache Disorders","volume":"29","author":"Gaul","year":"2009","journal-title":"Cephalalgia"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1468-2982.2005.00898.x","article-title":"Prevalence, Pattern and Predictors of Use of Complementary and Alternative Medicine (CAM) in Migraine Patients Attending a Headache Clinic in Italy","volume":"25","author":"Rossi","year":"2005","journal-title":"Cephalalgia"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ctim.2010.05.035","article-title":"The Use of Complementary and Alternative Medicine by Patients Attending a UK Headache Clinic","volume":"18","author":"Lambert","year":"2010","journal-title":"Complement. Ther. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1526-4610.2011.01917.x","article-title":"Complementary and Alternative Medicine Use Among Adults With Migraines\/Severe Headaches","volume":"51","author":"Wells","year":"2011","journal-title":"Headache J. Head Face Pain"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3390\/clinpract13030051","article-title":"Use of Pharmacological and Non-Pharmacological Strategies by Community-Dwelling Adults to Manage Migraine: A Systematic Review","volume":"13","author":"Marupuru","year":"2023","journal-title":"Clin. Pract."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1212\/01.WNL.0000078940.53438.83","article-title":"A Self-Administered Screener for Migraine in Primary Care The ID MigraineTM Validation Study","volume":"61","author":"Lipton","year":"2003","journal-title":"Neurology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1526-4610.2011.01916.x","article-title":"Diagnostic Accuracy of the ID Migraine: A Systematic Review and Meta-Analysis","volume":"51","author":"Cousins","year":"2011","journal-title":"Headache J. Head Face Pain"},{"key":"ref_27","unstructured":"British Association for the Study of Headache (BASH) (2019). National Headache Management System for Adults 2019, British Association for the Study of Headache (BASH)."},{"key":"ref_28","first-page":"1","article-title":"Treatment of Migraine Attacks and Prevention of Migraine: Guidelines by the German Migraine and Headache Society and the German Society of Neurology","volume":"3","author":"Diener","year":"2019","journal-title":"Clin. Transl. Neurosci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1071\/HC24020","article-title":"Evaluating Barriers for Effective Migraine Management in Aotearoa New Zealand","volume":"16","author":"McInnernay","year":"2024","journal-title":"J. Prim. Health Care"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Probyn, K., Bowers, H., Mistry, D., Caldwell, F., Underwood, M., Patel, S., Sandhu, H.K., Matharu, M., and Pincus, T. (2017). Non-Pharmacological Self-Management for People Living with Migraine or Tension-Type Headache: A Systematic Review Including Analysis of Intervention Components. BMJ Open, 7.","DOI":"10.1136\/bmjopen-2017-016670"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Tepper, S.J., Cirillo, J., Kim, E., L\u2019Italien, G., Tweedie, J.M., Lodaya, K., Riley, D., Pathan, F., Antaki, N., and Nathanson, B.H. (2023). The Temporal Trend of Placebo Response in Migraine Prevention from 1990 to 2021: A Systematic Literature Review and Meta-Analysis with Regression. J. Headache Pain, 24.","DOI":"10.1186\/s10194-023-01587-0"},{"key":"ref_32","unstructured":"Sanderson, J., Imlach, F., Kennedy, J., and Garrett, S. (2024). Primary Care Clinicians\u2019 Perspectives on Migraine Management in Aotearoa New Zealand: A Qualitative Study. J. Prim. Health Care, under review."},{"key":"ref_33","unstructured":"IPSOS Global Health Service Monitor (2024). IPSOS Health Service Report 2024. New Zealand Edition, IPSOS."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/head.14782","article-title":"Flexible Modeling of Headache Frequency Fluctuations in Migraine with Hidden Markov Models","volume":"65","author":"Dumkrieger","year":"2025","journal-title":"Headache J. Head Face Pain"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Serrano, D., Lipton, R.B., Scher, A.I., Reed, M.L., Stewart, W.F., Manack Adams, A., and Buse, D.C. (2017). Fluctuations in Episodic and Chronic Migraine Status over the Course of 1 Year: Implications for Diagnosis, Treatment and Clinical Trial Design. J. Headache Pain., 18.","DOI":"10.1186\/s10194-017-0787-1"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s40122-024-00690-7","article-title":"The Global Burden of Migraine: A 30-Year Trend Review and Future Projections by Age, Sex, Country, and Region","volume":"14","author":"Dong","year":"2024","journal-title":"Pain Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrneurol.2016.93","article-title":"Chronic Migraine: Risk Factors, Mechanisms and Treatment","volume":"12","author":"May","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Adams, A.M., Buse, D.C., Leroux, E., Lanteri-Minet, M., Sakai, F., Matharu, M.S., Katsarava, Z., Reed, M.L., Fanning, K., and Sommer, K. (2023). Chronic Migraine Epidemiology and Outcomes\u2014International (CaMEO-I) Study: Methods and Multi-Country Baseline Findings for Diagnosis Rates and Care. Cephalalgia, 43.","DOI":"10.1177\/03331024231180611"},{"key":"ref_39","unstructured":"Migraine Foundation Aotearoa New Zealand (2023). New Migraine Questions in the Next New Zealand Health Survey, Migraine Foundation Aotearoa New Zealand."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1590\/0004-282x-anp-2022-s112","article-title":"It Is Time Anti-CGRP Monoclonal Antibodies Be Considered First-Line Prophylaxis for Migraine","volume":"80","author":"Kubota","year":"2022","journal-title":"Arq. Neuropsiquiatr."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Sacco, S., Amin, F.M., Ashina, M., Bendtsen, L., Deligianni, C.I., Gil-Gouveia, R., Katsarava, Z., MaassenVanDenBrink, A., Martelletti, P., and Mitsikostas, D.-D. (2022). European Headache Federation Guideline on the Use of Monoclonal Antibodies Targeting the Calcitonin Gene Related Peptide Pathway for Migraine Prevention\u20142022 Update. J. Headache Pain, 23.","DOI":"10.1186\/s10194-022-01431-x"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/head.14692","article-title":"Calcitonin Gene-Related Peptide-Targeting Therapies Are a First-Line Option for the Prevention of Migraine: An American Headache Society Position Statement Update","volume":"64","author":"Charles","year":"2024","journal-title":"Headache J. Head Face Pain"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/12\/4023\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:47:47Z","timestamp":1760032067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/12\/4023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":42,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["jcm14124023"],"URL":"https:\/\/doi.org\/10.3390\/jcm14124023","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]}}}